Does Accidental Overcorrection of Symptomatic Hyponatremia in Chronic Heart Failure Require Specific Therapeutic Adjustments for Preventing Central Pontine Myelinolysis?
Renato De Vecchis(Presidio Ospedaliero), Nicola Maurea(Cancer Institute (WIA)), Anna Giasi(Società Italiana di Cardiologia), Arturo Cesaro(University of Campania "Luigi Vanvitelli"), Michel Noutsias(Martin Luther University Halle-Wittenberg), Carmelina Ariano(Casa Sollievo della Sofferenza), Carmela Cioppa(Presidio Ospedaliero)
Cited by 9
Related Papers
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry
|Cardiovascular Diabetology|2022|206
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry
|Pharmacological Research|2022|146
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
|Journal of Cardiac Failure|2011|116
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience
|Cancer Biology & Therapy|2010|108